PR96091 

OptraSCAN's Artificial Intelligence-Equipped Digital Pathology Scanner OS-SiA Granted U.S Patent for Scanning, Indexing and Analyzing of the Tissue Area at the Same Time

SAN JOSE, Calif., May 24, 2022 /PRNewswire=KYODO JBN/ --

    OptraSCAN(R) [https://www.optrascan.com/], the leading end-to-end digital

pathology solution provider, announced its digital pathology scanner OS-SiA has

been granted US patent - No 2020/0334814 A1 by the United States Patent and

Trademark Office. OS-SiA has inbuilt intelligence to scan, index and analyze

pathological samples simultaneously. This will benefit the end-user to view the

whole slide scanned image along with analyzed output as an overlay during their

review process.

    The patent describes a technique invented by OptraSCAN, the AI-enabled

digital pathology scanner OS-SiA

[https://www.optrascan.com/products/os-sia-ai-enabled-scanner] automatically

identifies specimens to scan and simultaneously analyzes the tissue or cell

area being scanned. OS-SiA is the industry's first AI-enabled digital scanner

that will provide real-time predictive analysis and actionable insights.

    "Currently, the digital pathology slide scanners are restricted to partial

or whole slide image acquisition and digitization into an image. Our

next-generation scanner OS-SiA scans and analyzes simultaneously eliminating

the need for additional processing applications," said Abhi Gholap, Founder &

CEO, OptraSCAN. "This patent highlights our constant efforts to improve the

adoption of digital pathology solutions and support the pathology community."

    OS-SiA can be embedded in the existing series of its cloud-enabled

brightfield scanners namely OS-Lite & OS-Ultra. The custom algorithms provide

real-time ROI detection while scanning, cell quantification for IHC/HNE

markers, and morphological measurements built using the core library. The whole

slide image can be viewed in a local / web-based / cloud-based image viewer.

The deep learning computational module is provided for self-learning in the

scanning device.

    "This is the kind of breakthrough we need to accelerate the adoption of

digital pathology, simultaneous scanning and analysis will help pathologists

make faster decisions and improve patient outcomes." Dr. Zu-Hua Gao MD, Medic

    About OptraSCAN, Inc:

    OptraSCAN(R) [https://www.optrascan.com/] are pioneers in the On-Demand

Digital Pathology(R) System, focused on delivering fully integrated, affordable

solutions that will maximize your return on investment and improve the

performance of your pathology services. An ISO 13485 certified company and CE

marked whole slide scanners for IVD use, OptraSCAN is working to eliminate the

barriers to 'Go Digital' no matter the size of the pathology lab, the lab's

throughput, or global location.

    OptraSCAN's end-to-end digital pathology solution provides effective

acquisition of whole slide images, viewing, storing, real-time sharing,

reporting and AI & ML based Image analysis solutions via On-Demand or outright

purchase model. Follow Us on LinkedIn

[https://in.linkedin.com/company/optra-scan] and Twitter

[https://mobile.twitter.com/optrascan].

    Photo: https://mma.prnewswire.com/media/1820629/OS_SIA_final.jpg

    Logo: https://mma.prnewswire.com/media/1517923/Optra_Scan_Logo.jpg

    Source: OptraSCAN Inc.